Summary of Significant Accounting Policies and Estimates - Schedule of Concentration Risk by Payer (Details) - Customer Concentration Risk	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025	Dec. 31, 2025
Payer 1 \| Revenue from Contract with Customer Benchmark
Product Information [Line Items]
Concentration risk, percentage	35.20%	37.70%	37.30%	43.30%
Payer 1 \| Accounts Receivable
Product Information [Line Items]
Concentration risk, percentage			20.70%		18.40%
Payer 2 \| Revenue from Contract with Customer Benchmark
Product Information [Line Items]
Concentration risk, percentage	12.10%	21.20%	13.80%	17.20%
Payer 2 \| Accounts Receivable
Product Information [Line Items]
Concentration risk, percentage			21.80%		22.60%
Payer 3 \| Revenue from Contract with Customer Benchmark
Product Information [Line Items]
Concentration risk, percentage	13.90%	12.90%	14.20%	10.90%
Payer 3 \| Accounts Receivable
Product Information [Line Items]
Concentration risk, percentage			14.20%

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.